2025, Degenerative Disc Disease and Patients - Chiropractic Pulse

Search:

DAY

WEEK

MONTH

YEAR

Jul 19 - Jul 25

Jul 12 - Jul 18

Jul 05 - Jul 11

Jun 28 - Jul 04

MORE

MORE

MORE

MORE

Select your country:
Sign up | Log in

2025

Degenerative Disc Disease

Patients

article thumbnail

ReGelTec Announces First Patient Treated in U.S. IDE Clinical Trial for HYDRAFIL System to Treat Chronic Low Back Pain

OrthoSpineNews

JUNE 18, 2025

BALTIMORE, June 18, 2025 -( BUSINESS WIRE )- ReGelTec Inc. , BALTIMORE, June 18, 2025 -( BUSINESS WIRE )- ReGelTec Inc. , The patient was enrolled by Kas Amirdelfan, M.D., The protocol includes an interim safety analysis when the first sixty patients complete their six-month follow-up visit. in Walnut Creek, Calif.

Degenerative Disc Disease

Degenerative Disc Disease Clinic Patients Vertebrae

article thumbnail

Study Confirms Significant Clinical Benefit of Neo Medical’s Force Control Technology™ in Spinal Fusion Surgery

OrthoSpineNews

APRIL 1, 2025

Yasser Abdalla , Head of Department of Neurosurgery, Nordwest-Krankenhaus, Sanderbusch (Germany), the study highlights the clear advantages of Neo’s platform in reducing early screw loosening and improving patient outcomes by managing unintended mechanical stress during surgery. Key Study Findings: 3.4x after one year 3.4

Degenerative Disc Disease

Degenerative Disc Disease Clinic Spine Treatment

Join 5,000+

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Dymicron Granted IDE Approval for Triadyme-C Artificial Disc

OrthoSpineNews

JULY 10, 2025

OREM, Utah, July 10, 2025 /PRNewswire/ — Dymicron ® , a privately held medical device company pioneering advanced spinal technologies, today announced that the United States (U.S.) The trial will enroll patients across several leading U.S. spine centers, with the first implantations expected in Q4 2025. IDE clinical trial.

Degenerative Disc Disease

Degenerative Disc Disease Spine Clinic Patients

article thumbnail

Phase 2 Trial of BRTX-100 in cLDD Continues to Generate Positive Preliminary Blinded Data

OrthoSpineNews

MAY 13, 2025

May 13, 2025 (GLOBE NEWSWIRE) — BioRestorative Therapies, Inc. We intend that the product will be used for the non-surgical treatment of painful lumbosacral disc disorders or as a complementary therapeutic to a surgical procedure. MELVILLE, N.Y.,

Degenerative Disc Disease

Degenerative Disc Disease Lower Back Pain Clinic Treatment

article thumbnail

Spinal Stabilization Technologies™ Announces Enrollment of First U.S. Patient in IDE Trial for PerQdisc™ Nucleus Replacement Device

OrthoSpineNews

MARCH 3, 2025

Spine Surgeon Dr. Frank Phillips Joins SST Board of Directors SAN ANTONIO, March 3, 2025 /PRNewswire/ — Spinal Stabilization Technologies, LLC (SST) has announced a significant milestone in its mission to revolutionize spinal care: the enrollment of the first U.S.

Degenerative Disc Disease

Degenerative Disc Disease Patients Spine Clinic

article thumbnail

Groundbreaking Spine Surgery Performed by Dr. Ehsan Jazini Marks New Era in Motion-Preserving Procedures

OrthoSpineNews

JUNE 25, 2025

First in the Nation to Perform Custom Combination of prodisc® C Nova and prodisc® C VIVO Disc Replacement. June 25, 2025 /PRNewswire/ — VSI® proudly announces a groundbreaking achievement in spine surgery, led by nationally recognized spine surgeon Dr. Ehsan Jazini. RESTON, Va.,

Degenerative Disc Disease

Degenerative Disc Disease Spine Neck Pain Musculoskeletal

article thumbnail

Vivex Biologics, Inc. Completes Subject Enrollment for its ASCEND Trial Evaluating VIA Disc NP™ for Symptomatic Disc Degeneration

OrthoSpineNews

JULY 29, 2025

Data readout expected in Q1 2026 MIAMI, July 29, 2025 (GLOBE NEWSWIRE) — Vivex Biologics, Inc., We are deeply grateful to our lead investigator, Dr. Paul Verrills, the co-investigators, site staff, and, most importantly, the patients for their participation.

Degenerative Disc Disease

Degenerative Disc Disease Lower Back Pain Physical therapy Clinic

article thumbnail

BioRestorative Announces Share Repurchase Program

OrthoSpineNews

JUNE 17, 2025

June 17, 2025 (GLOBE NEWSWIRE) — BioRestorative Therapies, Inc. In an outpatient procedure, BRTX-100 is to be injected by a physician into the patient’s damaged disc. The treatment is intended for patients whose pain has not been alleviated by non-invasive procedures and who potentially face the prospect of surgery.

Degenerative Disc Disease

Degenerative Disc Disease Lower Back Pain Treatment Clinic

article thumbnail

Cerapedics Announces FDA Approval of PearlMatrix™ P-15 Peptide Enhanced Bone Graft, The First and Only Proven Bone Growth Accelerator for Lumbar Fusion

OrthoSpineNews

JUNE 23, 2025

ASPIRE pivotal Level-1 PMA IDE study evaluated PearlMatrix vs. local autograft in single-level TLIF procedures: – Demonstrated statistically superior fusion speed; – Achieved over twice as many patients fused at six months; – Included ~60% high-risk patients WESTMINSTER, Colo., 3 The ASPIRE trial included 33 U.S.

Degenerative Disc Disease

Degenerative Disc Disease Spine Vertebrae Treatment

article thumbnail

Xtant Medical Announces Definitive Agreements for the Sale of its Coflex® and CoFix® Spinal Implants and All OUS Businesses to Companion Spine

OrthoSpineNews

JULY 8, 2025

July 8, 2025 /PRNewswire/ — Xtant Medical Holdings, Inc. The transaction is expected to close in the third quarter of 2025. We are confident this will position us to better serve the needs of pain management physicians, spine surgeons, and their patients on a global scale, strengthening specifically our presence in the U.S.

Spine

Spine Degenerative Disc Disease Musculoskeletal Treatment

article thumbnail

Cerapedics Announces First U.S. Patient Treated with PearlMatrix™ P-15 Peptide Enhanced Bone Graft following FDA approval

OrthoSpineNews

JULY 8, 2025

July 8, 2025 /PRNewswire/ — Cerapedics Inc., a global, commercial-stage orthopedics company dedicated to redefining the path to bone repair, today announced the successful completion of the first patient treated with PearlMatrix P-15 Peptide Enhanced Bone Graft following the recent U.S. WESTMINSTER, Colo.,

Degenerative Disc Disease

Degenerative Disc Disease Patients Spine Vertebrae

article thumbnail

BioRestorative Therapies Reports First Quarter 2025 Financial Results and Provides Business Update

OrthoSpineNews

MAY 14, 2025

May 14, 2025 (GLOBE NEWSWIRE) — BioRestorative Therapies, Inc. BioRestorative, BRTX or the Company) (NASDAQ: BRTX ) , a regenerative medicine innovator focused on stem cell-based therapies and products, today reported financial results for the first quarter ended March 31, 2025 and provided an update on its business.

Degenerative Disc Disease

Degenerative Disc Disease Lower Back Pain Neck Pain Treatment

article thumbnail

Aurora Spine Corporation Announces Completion of Enrollment in Groundbreaking REFINE Study: First Prospective, Multi-Center, Multi-Specialty Study on Lumbar Interlaminar Fusion

OrthoSpineNews

MARCH 10, 2025

The REFINE study, designed to bridge the gap between conservative treatments and more invasive surgical options, has successfully enrolled its full cohort of patients across multiple centers in the United States. The data weve gathered is critical, its not just numbers, its the foundation for improving patient lives. CARLSBAD, Calif.,

Degenerative Disc Disease

Degenerative Disc Disease Spine Musculoskeletal Clinic

article thumbnail

BioRestorative Reports Compelling Preliminary Data for FDA-Fast-Tracked BRTX-100 – an Autologous Stem Cell Therapy to Treat Chronic Lumbar Disc Disease

OrthoSpineNews

JUNE 13, 2025

June 13, 2025 (GLOBE NEWSWIRE) — BioRestorative Therapies, Inc. This data was shared at the prestigious ISSCR 2025 Annual Meeting in Hong Kong by Francisco Silva, Vice President of Research and Development. In an outpatient procedure, BRTX-100 is to be injected by a physician into the patient’s damaged disc.

Degenerative Disc Disease

Degenerative Disc Disease Lower Back Pain Clinic Treatment

article thumbnail

Global Spine, MIS and VCF Markets to Reach $38B by 2031, Fueled by Robotic Surgery, MIS Growth, and Next-Gen Implants – iData Research

OrthoSpineNews

MAY 6, 2025

VANCOUVER, BC,May 6, 2025/PRNewswire/ – New global reports on the Spine and Vertebral Compression Fracture (VCF) , along with Minimally Invasive Spine Surgery (MIS) markets, from iData Research reveal major shifts reshaping the industry. In parallel, minimally invasive spine surgery is gaining traction worldwide.

Degenerative Disc Disease

Degenerative Disc Disease Spine Health Patients

article thumbnail

Spinal Implants Market to Grow by USD 3.55 Billion from 2025-2029, Driven by Rising Spinal Disorder Prevalence, AI’s Impact on Market Trends – Technavio

OrthoSpineNews

FEBRUARY 10, 2025

10, 2025/PRNewswire/ — Report on how AI is redefining market landscape – The global spinal implants market size is estimated to grow byUSD 3.55 billionfrom 2025-2029, according to Technavio. Market growth 2025-2029 USD 3554.5 Patients benefit from quicker recovery, less postoperative pain, and reduced hospital stays.

Degenerative Disc Disease

Degenerative Disc Disease Scoliosis Clients Spine

article thumbnail

Prosthetic Disc Nucleus Market Set to Reach $265.8 Million by 2034, TMR Forecasts 8.2% CAGR – TMR Insights

OrthoSpineNews

JANUARY 28, 2025

The trend toward minimally invasive surgeries and innovations in prosthetic discs with high biocompatibility is further fueling market expansion. 28, 2025 (GLOBE NEWSWIRE) — The global Prosthetic Disc Nucleus Market (Markt fr Bandscheibenkernprothesen) has been valued at US$ 110.6

Degenerative Disc Disease

Degenerative Disc Disease Spine Chronic Pain Treatment